Company Analysis National Research Corporation
1. Summary
Advantages
- Dividends (5.08%) are higher than the sector average (0.5261%).
- The company's current efficiency (ROE=61.77%) is higher than the sector average (ROE=14.17%)
Disadvantages
- Price (16.04 $) is higher than fair price (11.29 $)
- The stock's return over the last year (-27.45%) is lower than the sector average (0%).
- Current debt level 47.29% has increased over 5 years from 30.89%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| National Research Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1% | -21.2% | -0.3% |
| 90 days | 49.9% | -21.5% | 10% |
| 1 year | -27.5% | 0% | 9.7% |
NRC vs Sector: National Research Corporation has significantly underperformed the "Healthcare" sector by -27.45% over the past year.
NRC vs Market: National Research Corporation has significantly underperformed the market by -37.18% over the past year.
Stable price: NRC is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NRC with weekly volatility of -0.528% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (16.04 $) is higher than the fair price (11.29 $).
Price is higher than fair: The current price (16.04 $) is 29.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (16.68) is lower than that of the sector as a whole (63.23).
P/E vs Market: The company's P/E (16.68) is lower than that of the market as a whole (89.86).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (13.21) is lower than that of the sector as a whole (18.83).
P/BV vs Market: The company's P/BV (13.21) is higher than that of the market as a whole (9.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.89) is lower than that of the sector as a whole (32.67).
P/S vs Market: The company's P/S indicator (2.89) is lower than that of the market as a whole (10.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (11.42) is lower than that of the sector as a whole (274.42).
EV/Ebitda vs Market: The company's EV/Ebitda (11.42) is lower than that of the market as a whole (50.71).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -6.71% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-6.71%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).
5.4. ROE
ROE vs Sector: The company's ROE (61.77%) is higher than that of the sector as a whole (14.17%).
ROE vs Market: The company's ROE (61.77%) is higher than that of the market as a whole (11.64%).
5.5. ROA
ROA vs Sector: The company's ROA (19.44%) is higher than that of the sector as a whole (1.18%).
ROA vs Market: The company's ROA (19.44%) is higher than that of the market as a whole (6.88%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.08% is higher than the average for the sector '0.5261%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.08% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 5.08% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (46.21%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
